Roughly 5 million Americans have Alzheimer’s disease – the most common form of dementia that often steals someone’s memory, cognition and personality. And this number is expected to triple by 2050. While death rates have steadily declined for most major diseases, including heart disease, breast cancer, prostate cancer, stroke and HIV/AIDS, deaths from Alzheimer’s disease have risen 66 percent during the same period.  The burden to the economy, society and family units is high. For years scientists have been slowly unraveling the mechanisms behind Alzheimer’s disease and at least 80 medicines  have been tested to target Alzheimer’s and its symptoms, but there has been no significant breakthrough to date. This session will provide an overview of Alzheimer’s – what it is, its prevalence, important milestones in scientific discovery, challenges to finding a cure, as well as the current and anticipated cost to the economy and society at large.

Learning Objectives:

  • Review the progress and obstacles of current research investigations and the need to explore other R&D and drug development models
  • List the economic, societal and medical costs associated with Alzheimer’s disease
  • Explore how this disease changes family dynamics and the physical and emotional stress on caregivers

Ability Level: All

Session ID: 2107

myBIO Chatter

Speakers (3)

contact_8363 Marc Boutin Executive Vice President & Chief Operating Officer National Health Council
contact_9987 Gail Hunt President and Chief Executive Officer National Alliance for Caregiving
contact_9993 Jeffrey Nye, MD, PhD Vice President, Neuroscience Innovation and Scientific Partnership Strategy Janssen Research and Development, LLC

Moderators (1)

contact_2493 Melissa Stevens Deputy Executive Director FasterCures

Who's Attending (1)

See all